FB Pixel no scriptBiotechnology | KrASIA
MENU
KrASIA

Biotechnology

Insights

Is it worth spending RMB 200,000 a year to delay the onset of Alzheimer’s disease?

With no cure in sight for Alzheimer’s disease, caregivers struggle to weigh the odds of pursuing costly treatments.

9 mins read
  • 2024 could see Chinese pharma matching up to global giants in the race for small nucleic acid drug breakthroughs.

    Insights

    China’s pharmaceutical industry bets big on small nucleic acid drugs in 2024

    11 mins read

Most Recent

See All